vs
Side-by-side financial comparison of Flora Growth Corp. (FLGC) and Cellyan Biotechnology Co., Ltd (HKPD). Click either name above to swap in a different company.
Flora Growth Corp is a global cannabis and wellness enterprise cultivating, processing, and distributing premium cannabis and hemp-derived products including consumer goods, skincare lines, and therapeutic formulations. It operates mainly across Latin American, North American, and European markets, serving recreational and medicinal cannabis segments.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
Revenue
FLGC
HKPD
| Q4 25 | $-654.0K | — | ||
| Q3 25 | $9.7M | — | ||
| Q2 25 | $14.8M | — | ||
| Q1 25 | $11.8M | — | ||
| Q4 24 | $-5.1M | — | ||
| Q3 24 | $7.2M | — | ||
| Q2 24 | $15.7M | — |
Net ProfitFLGCHKPD
| Q4 25 | $-109.9M | — | ||
| Q3 25 | $-6.7M | — | ||
| Q2 25 | $-2.4M | — | ||
| Q1 25 | $-758.0K | — | ||
| Q4 24 | $-6.1M | — | ||
| Q3 24 | $-3.8M | — | ||
| Q2 24 | $-2.6M | — |
Gross MarginFLGCHKPD
| Q4 25 | 673.4% | — | ||
| Q3 25 | 3.4% | — | ||
| Q2 25 | 19.1% | — | ||
| Q1 25 | 24.5% | — | ||
| Q4 24 | 104.6% | — | ||
| Q3 24 | 6.8% | — | ||
| Q2 24 | 20.2% | — |
Operating MarginFLGCHKPD
| Q4 25 | 22606.0% | — | ||
| Q3 25 | -33.5% | — | ||
| Q2 25 | -17.3% | — | ||
| Q1 25 | -8.3% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -29.2% | — | ||
| Q2 24 | -22.6% | — |
Net MarginFLGCHKPD
| Q4 25 | 16804.7% | — | ||
| Q3 25 | -68.3% | — | ||
| Q2 25 | -16.3% | — | ||
| Q1 25 | -6.4% | — | ||
| Q4 24 | 120.5% | — | ||
| Q3 24 | -52.1% | — | ||
| Q2 24 | -16.8% | — |
EPS (diluted)FLGCHKPD
| Q4 25 | $-34.29 | — | ||
| Q3 25 | $-9.05 | — | ||
| Q2 25 | $-0.11 | — | ||
| Q1 25 | $-0.04 | — | ||
| Q4 24 | $-38.40 | — | ||
| Q3 24 | $-11.03 | — | ||
| Q2 24 | $-0.21 | — |
